Avelumab (anti-PD-L1) in platinum-resistant/refractory ovarian cancer: JAVELIN Ovarian 200 Phase III study design
| Image |  |
|---|---|
| Description | scientific article published on 27 March 2018 |
| Author/s |
author: Keiichi Fujiwara Bradley J. Monk |
| Publication date | March 27, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |